Authors
Latest:
The Cost of Adherence Mismeasurement in Serious Mental Illness: A Claims-Based AnalysisThis study demonstrates that common pharmacy claims-based measures underestimate the effect of actual adherence on inpatient costs among patients with serious mental illness.
Latest:
Implementing an Oncology Precision Medicine Clinic in a Large Community Health SystemPrecision medicine is increasingly being utilized in oncology. Aurora Health Care has implemented Syapse software to integrate molecular data into the electronic health record to accommodate precision medicine findings.
Latest:
Impact of Statin Guidelines on Statin Utilization and Costs in an Employer-Based Primary Care ClinicAdherence to clinical guidelines in practice is often suboptimal and controversial. This study compares actual statin utilization and cost with full adoption of major clinical guidelines in a real-world population.
Latest:
Single- Versus Multiple-Tablet HIV Regimens: Adherence and Hospitalization RiskSingle-tablet regimens are associated with higher adherence rates, decreased hospitalizations, and a higher proportion of patients with undetectable viral load compared with multiple-tablet regimens in patients with HIV/AIDS.
Latest:
Co-payment Policies and Breast and Cervical Cancer Screening in MedicaidCo-payments for preventive services can discourage breast and cervical cancer screening among Medicaid enrollees, particularly breast cancer screening, which is more costly and time-consuming.
Latest:
Connected Care: Improving Outcomes for Adults With Serious Mental IllnessCase study of a payer-led intervention to improve coordination of care for adult Medicaid beneficiaries with serious mental illness.
Latest:
Catheter Management After Benign Transurethral Prostate Surgery: RAND/UCLA Appropriateness CriteriaThis manuscript synthesizes findings from a multidisciplinary panel following the RAND/UCLA Appropriateness Method to guide standardization of urinary catheter use after transurethral prostate surgery.
Latest:
The Value of Specialty Pharmaceuticals - A Systematic ReviewThis study examines whether patients treated with specialty pharmaceuticals have improved outcomes compared with patients treated with conventional therapies, and evaluates costs associated with these treatments.
Latest:
Cost-effectiveness of Brentuximab Vedotin With Chemotherapy in Treatment of CD30-Expressing PTCLAn economic model based on the ECHELON-2 trial demonstrated cost-effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma (PTCL).
Latest:
Pharmaceuticals From Development to Practice: Learnings From an Online CurriculumThis article summarizes the outcomes from a pilot online curriculum on off-label prescribing, appraising pharmaceutical information, and talking with patients about advertised medications.
Latest:
Patient Attribution: Why the Method MattersReliable identification of the physician–patient relationship is necessary for accurate evaluation. Standardization of evidence-based attribution methods is essential to improve the value of healthcare.
Latest:
Collection of Language Data and Services Provided by Health PlansHealth plans have made substantial progress in the collection of language data and many are offering options for language services.
Latest:
A Meta-analysis Update: Percutaneous Coronary InterventionsMeta-analyses of percutaneous coronary interventions in stable coronary artery disease are updated to include 2 recent large randomized controlled trials.
Latest:
Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide StudyOne-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.
Latest:
Mortality, Outcomes, and Healthcare Costs in T2DM Patients at Risk for Cardiovascular DiseaseTargeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.
Latest:
Cost of Care for Malignant and Benign Renal MassesMethods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.
Latest:
Quality Measurement of Medication Monitoring in the Meaningful Use EraShifting from claims to integrated electronic health records to calculate quality metrics will improve reported quality attributable to data capture changes, not true quality improvements.
Latest:
Assessing Electronic Health Record Implementation Challenges Using Item Response TheoryIt is unclear which barriers cause the greatest threats to the successful implementation of an electronic health record (EHR). This paper prioritizes the potential threats to EHR adoption using a novel analytic strategy: item response theory.
Latest:
Innovation in Plain SightInnovations are powering the evolution of patient-centered care, and health plans are at the center of this innovation story.
